Cargando…

Developing standard safety outcomes for COVID-19 vaccines

Detalles Bibliográficos
Autor principal:	Buttery, Jim P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953438/ https://www.ncbi.nlm.nih.gov/pubmed/33888324 http://dx.doi.org/10.1016/j.vaccine.2021.03.004

Ejemplares similares

Information systems for vaccine safety surveillance
por: Buttery, Jim P, et al.
Publicado: (2022)

Planning for COVID-19 vaccines safety surveillance
por: Kochhar, Sonali, et al.
Publicado: (2020)

COVID-19 vaccine trials: Duty of care and standard of prevention considerations
por: Singh, Jerome Amir
Publicado: (2020)

A Commentary on Realities of Developing COVID-19 Vaccines Discussed through the Global Health Safety Perspective
por: Al-Qahtani, Wedad Saeed, et al.
Publicado: (2021)

Assessing the long-term safety and efficacy of COVID-19 vaccines
por: Majeed, Azeem, et al.
Publicado: (2021)

Vaccine safety in Australia during the COVID-19 pandemic: Lessons learned on the frontline
por: Laemmle-Ruff, Ingrid, et al.
Publicado: (2022)

COVID-19 vaccine safety questions and answers for healthcare providers (CONSIDER)
por: Kochhar, Sonali, et al.
Publicado: (2021)

Does it matter that standard preparedness indices did not predict COVID-19 outcomes?
por: Stoto, Michael A., et al.
Publicado: (2023)

The Role of Standards for Communicable Disease Prevention and Control in Protecting People’s Health and Safety During COVID-19
por: Feng, Lan, et al.
Publicado: (2020)

COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety
por: Kricorian, Katherine, et al.
Publicado: (2021)

Commentary: Standardization of procedures for health care providers safety in the coronavirus disease 2019 (COVID-19) era, with an eye to the future
por: Scarci, Marco, et al.
Publicado: (2020)

Rapid evaluation of the safety of COVID-19 vaccines: how well have we done?
por: Miller, Elizabeth
Publicado: (2022)

Obligation Is Not a Compulsion—The Quality of the Law and the Effectiveness and Safety of Vaccination against COVID-19
por: Kocańda, Kamila, et al.
Publicado: (2022)

Victorian Specialist Immunisation Services (VicSIS) – bolstering adult clinics for COVID-19 vaccines
por: Gordon, Sally F., et al.
Publicado: (2022)

India’s cost-effective COVID-19 vaccine development initiatives
por: Chakraborty, Chiranjib, et al.
Publicado: (2020)

The next frontier in vaccine safety and VAERS: Lessons from COVID-19 and ten recommendations for action
por: Rizk, John G., et al.
Publicado: (2021)

Vaccine Safety Surveillance Systems: Critical Elements and Lessons Learned in the Development of the US Vaccine Safety Datalink’s Rapid Cycle Analysis Capabilities
por: Davis, Robert L.
Publicado: (2013)

The race to a COVID-19 vaccine: opportunities and challenges in development and distribution
por: Burgos, Rodrigo M, et al.
Publicado: (2021)

Development of vaccines for influenza disease: Opportunity costs of the COVID-19 pandemic
por: Wiemken, Timothy L., et al.
Publicado: (2021)

Advances in skin science enable the development of a COVID-19 vaccine
por: Falo, Louis D.
Publicado: (2020)

Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine
por: Engeland, Christine E.
Publicado: (2022)

Challenges in Assessing COVID-19 Vaccines Safety Signals—The Case of ChAdOx1 nCoV-19 Vaccine and Corneal Graft Rejection
por: Bizimungu, Christelle, et al.
Publicado: (2023)

COVID-19 Vaccine
por: Fernandes, Amanda, et al.
Publicado: (2021)

The development of COVID-19 vaccines in the United States: Why and how so fast?
por: Kuter, Barbara J., et al.
Publicado: (2021)

Considerations on the clinical development of COVID-19 vaccine from trial design perspectives
por: Jiang, Zhiwei, et al.
Publicado: (2020)

Vaccines are not yet a silver bullet: The imperative of continued communication about the importance of COVID-19 safety measures
por: Su, Zhaohui, et al.
Publicado: (2021)

COVID-19 vaccine safety monitoring in low and middle income countries – Time for a bold new approach
por: Straus, Walter, et al.
Publicado: (2022)

A framework for public involvement at the design stage of NHS health and social care research: time to develop ethically conscious standards
por: Pandya-Wood, Raksha, et al.
Publicado: (2017)

COVID‐19 vaccination in children and university students
por: Ioannidis, John P. A.
Publicado: (2021)

COVID-19 vaccination in Israel
por: Muhsen, Khitam, et al.
Publicado: (2021)

The Time for COVID-19 Vaccination
por: Domingo, Esteban, et al.
Publicado: (2021)

Designing Meningitis Vaccines
por: Buttery, Jim P, et al.
Publicado: (2000)

Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines
por: Forman, Rebecca, et al.
Publicado: (2020)

COVID-19 vaccination in the UK: Addressing vaccine hesitancy
por: Sonawane, Kalyani, et al.
Publicado: (2021)

COVID-19 vaccines and vaccination: how prepared is Africa?
por: Ariyo, Olumuyiwa Elijah, et al.
Publicado: (2021)

COVID-19 trials in Italy: A call for simplicity, top standards and global pooling
por: Maggioni, Aldo P., et al.
Publicado: (2020)

Behind the Scenes Heroes: The COVID-19 Vaccine Data and Safety Monitoring Board
por: Corey, Lawrence
Publicado: (2021)

Digital tools, multidisciplinarity and innovation for communicating vaccine safety in the COVID-19 era
por: Gesualdo, Francesco, et al.
Publicado: (2021)

Excess mortality: the gold standard in measuring the impact of COVID-19 worldwide?
por: Beaney, Thomas, et al.
Publicado: (2020)

Should COVID-19 vaccination be made mandatory?
por: Iyengar, Karthikeyan P, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p6v7if73qepjln2djtqsq1v2ju